Bora Pharmaceuticals Co., Ltd., a pharmaceutical manufacturer, has appointed Jean-Baptiste (JB) Agnus as Chief Commercial Officer. In this role, he will lead Bora’s commercial strategy for its sterile injectables and complex small molecule offerings and play a key role in its M&A and strategic partnership initiatives.

Agnus joins Bora Group from KBI Biopharma, where he led global business development. Prior to that, he held various senior leadership roles in business development at AGC Biologics, Ajinomoto Bio-Pharma Services, Novasep, and Isochem.

He holds a bachelor’s degree in organic chemistry from Université Paul Sabatier Toulouse III, Toulouse, France, and a master’s degree in chemical engineering from Centrale Méditerranée, Marseille, France.

“I am thrilled to welcome JB, who brings with him more than 25 years of biopharmaceutical industry experience. I look forward to working with him to meet the needs of our partners and the patients we serve together and support this rapidly growing organization,” commented J.D. Mowery, President of Bora’s CDMO Division. “We at Bora are deeply committed to providing the highest standards of quality and customer service. JB’s experience and leadership will serve us well as we implement growth and investment strategies to better serve our clients and patients worldwide.”